Influenza News and Research

Latest Influenza News and Research

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

4 Apr 2022
Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

3 Apr 2022
Global study demonstrates some benefits of flu vaccine in people with heart failure

Global study demonstrates some benefits of flu vaccine in people with heart failure

3 Apr 2022
Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

1 Apr 2022
TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

1 Apr 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
How effective are household cleaning agents against SARS-CoV-2?

How effective are household cleaning agents against SARS-CoV-2?

31 Mar 2022
NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

31 Mar 2022
Study identifies implications of long-COVID on long term physical and mental health

Study identifies implications of long-COVID on long term physical and mental health

31 Mar 2022
A summary of SARS-CoV-2 RNA-protein interactome studies

A summary of SARS-CoV-2 RNA-protein interactome studies

30 Mar 2022
Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

30 Mar 2022
Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

30 Mar 2022
Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

29 Mar 2022
Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

29 Mar 2022
Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

29 Mar 2022
Algal metabolites as novel drugs against viruses

Algal metabolites as novel drugs against viruses

29 Mar 2022
New compound delivered in a nasal spray effectively treats delta variant infection in mice

New compound delivered in a nasal spray effectively treats delta variant infection in mice

29 Mar 2022
Is COVID-19 vaccination during pregnancy safe?

Is COVID-19 vaccination during pregnancy safe?

29 Mar 2022
Evaluating severity of influenza infection in ferrets with COVID-19 history

Evaluating severity of influenza infection in ferrets with COVID-19 history

28 Mar 2022
Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

28 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback